Mortgage Educators Tackle Sales, Reverse Mortgages

Reverse mortgages and loan originator sales development are among some of the topics covered in recent releases of mortgage-related education services and events.

An online version of OriginationPro Mortgage School is designed to fulfill the needs of an aging sales force within the mortgage industry, The Hershman Group said Monday.

The announcement from the Centreville, Virginia-based company indicated that the average age of the industry’s sales force grown past 50 years old since the financial crisis.


…read more

From:: Financing

FHFA’s Watt: Congress needs to handle housing finance reform

In recent weeks, several different groups tried to exert public pressure on the Federal Housing Finance Agency in an attempt to end the housing finance system’s current status quo. Up to this point, the FHFA and its director, Mel Watt, would not responded directly to these efforts. But now, Watt is responding directly to those public salvos, albeit much more quietly than the trade groups or the politicians. …read more

From:: Real Estate Wire

California Originations Reach 9-Year High

Mortgage production in the Golden State last year ascended to the highest level in nine years. Broker originations, though, were mixed.

During 2015, there were 537,757 home loans originated for $179.3 billion by mortgage companies licensed in the state of California.

It was the strongest year of mortgage production since 2006, when 881,348 residential loans were originated for $254.8 billion.


…read more

From:: Financing

Juno shares up 29% as FDA allows resumption of clinical trial for cancer drug

Juno Therapeutics Inc. shares rose nearly 30% late Tuesday after the pharmaceutical company said the Food and Drug Administration allowed it to resume the mid-stage clinical trial of a cancer drug put on hold last week after two deaths. The drug, known as JCAR15, is supplied to patients suffering from an acute form of leukemia. Shares of Juno had ended the regular session up 1.7%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Michaels Cos. shares slip on secondary offering, outlook

Michaels Cos. shares slipped in the extended session Tuesday after the arts and crafts retailer said certain shareholders were selling a large chunk of stock in a secondary offering. Michaels shares declined 3.6% to $27.85 after hours. The company said certain shareholders were selling 11 million shares, and that it would buy 1 million of those shares. As a result, Michaels said it expects second-quarter results in the “lower-to-middle range” of its previous guidance. In June, Michaels forecast earnings of 16 cents to 18 cents a share for the second quarter. Analysts surveyed by FactSet estimate earnings of 18 cents a share.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Oil falls as sources say API data show U.S. crude supply up 2.2 mln bbls

Oil futures fell in electronic trading Tuesday after the American Petroleum Institute reported that U.S. crude supplies unexpectedly rose by 2.2 million barrels for the week ended July 8, according to sources. The closely watched Energy Information Administration report will be released Wednesday. Analysts polled by S&P Global Platts forecast a fall of 3.25 million barrels for crude inventories. August crude was at $46.44 a barrel in electronic trading, down from the contract’s settlement of $46.80 on the New York Mercantile Exchange.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

FDA approves Pfizer’s pneumonia vaccine for infants, younger adults

Pfizer Inc. said late Tuesday the Food and Drug Administration has approved its pneumonia vaccine Prevnar 13 for adults ages 18 through 49 and for infants and young children. The vaccine is already approved for adults over 50 and for children aged 6 to 17 years. The vaccine protects against 13 strains of bacteria causing pneumonia and other illnesses. Prevnar was first approved in the European Union for use in infants and young children in 2009, and is included in immunization programs in 102 countries, Pfizer said. Shares of Pfizer rose 0.1% in late trading after ending the regular session up 0.3%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

S&P 500, Dow close at fresh records

The Dow Jones Industrial Average finished at a record on Tuesday, joining the S&P 500 index at an all-time closing high as a rally in oil prices and stronger-than-expected earnings from Alcoa Inc. vaulted stocks to new heights. The record for the the blue-chip benchmark comes a day after the S&P 500 index set an all-time closing high. The Dow added 120.74 points, or 0.7%, to 18,347.67, ending at a record for the first time in nearly 14 months. The blue-chip index set an intraday high at 18,371.95. The S&P 500 climbed 14.98 points, or 0.7%, to 2,152.14, a few points off its all-time intraday high of 2,155.49. The Nasdaq Composite advanced 34.18 points, or 0.7% to 5,022.82, erasing its losses in 2016.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Brexit Vote Drives down Mortgage Rates, Results Show

By Susanne Dwyer

Slow growth in China and the Brexit vote in the U.K. have played a major role in driving down mortgage rates, according to Freddie Mac’s recently released monthly Outlook for July. In the most recent Primary Mortgage Market Survey, the 30-year fixed-rate mortgage fell to 3.41 percent, just slightly above the all-time record low. This is likely to result in a boost in housing activity, particularly refinance, as homeowners take advantage of the current low rates.

“With the U.K.’s decision to exit from the European Union, global risks increased substantially, leading us to revise our views for the remainder of 2016 and all of 2017,” says Sean Becketti, chief economist, Freddie Mac. “Nonetheless, the turbulence abroad should continue to create demand for U.S. Treasuries and keep mortgage rates near historic lows; thereby, allowing home sales to have their best year in a decade, along with a boost in refinance activity.”

Results lead experts to expect growth rebound in the remaining quarters of 2016 to show GDP at 1.9 and 2.2 percent in 2016 and 2017. In light of recent global pressures, the 30-year, fixed-rate mortgage forecast has been revised down for both 2016 (by 30 basis points) and 2017 (by 50 basis points) to 3.6 percent and 4.0 percent, respectively.

Based on these low mortgage rates, expect the refinance share of originations to rise to 49 percent for 2016, 8 percentage points above last month’s forecast. This translates to about $100 billion more in originations, bringing the total for 2016 to $1,825 billion.

With June’s much-improved employment report over May’s release, expect unemployment to average 4.9 percent in 2016 and 4.8 percent in 2017.

The house price appreciation forecast for 2016 remains at 5.0 percent, and in 2017, 4.0 percent.

For more information, visit www.freddiemac.com.

…read more

From:: Finance and Economy